MARKET

ZFGN

ZFGN

Zafgen
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.7600
+0.0100
+1.33%
After Hours: 0.7600 0 0.00% 16:05 11/15 EST
OPEN
0.7500
PREV CLOSE
0.7500
HIGH
0.7600
LOW
0.7305
VOLUME
140.59K
TURNOVER
--
52 WEEK HIGH
10.08
52 WEEK LOW
0.6300
MARKET CAP
28.40M
P/E (TTM)
-0.5372
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ZFGN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ZFGN News

  • Zafgen reports Q3 results
  • seekingalpha.11/07 03:01
  • Zafgen Q3 EPS $(0.35) Misses $(0.27) Estimate
  • Benzinga.11/06 21:02
  • Zafgen Reports Third Quarter 2019 Financial Results
  • GlobeNewswire.11/06 21:01
  • Zafgen 13G Filing From EcoR1 Capital Shows 7% Stake
  • Benzinga.10/15 21:17

More

Industry

Biotechnology & Medical Research
+1.25%
Pharmaceuticals & Medical Research
+1.34%

Hot Stocks

Name
Price
%Change

About ZFGN

Zafgen, Inc., is a clinical-stage biopharmaceutical company. The Company uses its proprietary methionine aminopeptidase 2 (MetAP2) biology platform to develop novel therapies for patients affected by complex metabolic diseases. Its product candidate is ZGN-1061 which is a novel fumagillin-class MetAP2 inhibitor that is used to treat type 2 diabetes and other related metabolic disorders. Type 2 diabetes is a prevalent, chronic, progressive and multifactorial disorder that leads to increased microvascular and macrovascular disease and as such increases risk of death from cardiovascular disease, stroke, and kidney failure. Its MetAP2 development candidate ZGN-1258 is administered by subcutaneous injection. ZGN-1258 is used for the treatment of Prader-Willi syndrome (PWS). PWS is a rare and complex genetic disorder characterized by physiologic, cognitive and behavioral symptoms including hyperphagia, uncontrollable hunger and its related behaviors, and obesity.
More

Webull offers Zafgen Inc (ZFGN) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.